Comparing interferon‐free with interferon‐based regimens in HCV patients: Rogers phenomenon and Simpson’s paradox - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Journal of Viral Hepatitis Année : 2020

Comparing interferon‐free with interferon‐based regimens in HCV patients: Rogers phenomenon and Simpson’s paradox

Résumé

Comparisons of time-to-event clinical outcomes between patients with or without a sustained virological response (SVR) after treatment of chronic hepatitis C infection have been repeatedly reported in emphasizing the potential clinical impact of treatment. Combining recently published data from different therapeutic eras with simple examples, we show that comparisons of incidence rates by SVR status between patients treated with interferon-based and interferon-free regimens are flawed through confounding by prognosis. The relevant analysis for evaluating and comparing the clinical impact of these regimens should be a comparison between randomized treatment groups, irrespective of the SVR status.
Fichier principal
Vignette du fichier
Carrat_JViralHepatitis_RogersSimpson_190913_acceptedversion.pdf (124.58 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02437336 , version 1 (13-01-2020)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Fabrice Carrat, Pierre Nahon, Hélène Fontaine, Stanislas Pol, Gilles Hejblum. Comparing interferon‐free with interferon‐based regimens in HCV patients: Rogers phenomenon and Simpson’s paradox. Journal of Viral Hepatitis, 2020, 27 (3), pp.329-332. ⟨10.1111/jvh.13225⟩. ⟨hal-02437336⟩
119 Consultations
153 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More